Shlomo Melmed

Shlomo Melmed at Cedars-Sinai has been the preeminent pituitary tumor researcher, making foundational contributions to understanding pituitary adenoma biology and treatment. His work on GH-secreting pituitary tumors (acromegaly) — demonstrating increased cancer risk and developing treatment algorithms — and his contributions to pituitary tumor genetics and medical management with somatostatin analogues and dopamine agonists have defined the field.